Results with Lifescozul™Gastric Intestinal Cancer
Introduction to the case
Diagnosed with grade 4 gastric cancer, the most advanced cancer in existence, the stomach of the Maria was removed. The doctors gave her one month to live. So Maria was started on her own with LifEscozul (escozul, blue scorpion venom), the most advanced and effective formulation of blue scorpion venom. Two years later Maria is still with us. Discover her Results.
María Leal Vega, Female, 73 years old at the beginning of treatment with LifEscozul.
Anorexia and Depression.
July 5, 2018.
Moderately differentiated adenocarcinoma of the stomach, with pulmonary and lymph node metastases.
Maria began to present constant abdominal pain and sustained weight loss that forced her to visit a doctor. She underwent a study and it was determined that she was suffering from gastric cancer. She was immediately scheduled for a total gastrectomy which was performed in April 2018. However after the operation she presented fluid in her lung and underwent a surgical cleaning, during which three tumors were found in her lung.
A month later it was confirmed through a new biopsy that there was involvement of adenocarcinoma in the parietal peritoneum and pleura. At this point the only proposal was a palliative chemotherapy and he was sent home as he had at most one month to live.
It is at this point that Maria's daughter, Pamela, contacts us to evaluate the case and see if it is possible to include her in the Protocol.
Maria's case was evaluated by our Specialized Medical Committee and it was decided to work with a differentiated dose, staggered in order to provide quality of life. A physician and a scientific advisor were assigned to the case. The principle of not creating false expectations due to the advanced stage of the case was maintained at all times.
By the time Maria entered the LifEscozul Protocol (escozul, blue scorpion venom) the most advanced and effective formulation of blue scorpion venom, she was no longer receiving any treatment.
Evolution with LifEscozul™ and actual results
Maria started treatment with LifEscozul on July 5, 2018.
Maria's daughter, Pamela, is the one who has always kept in touch with LifEscozul's medical team, updating us on her mother's condition.
Report July 27, 2018 Pamela writes to tell us about the remarkable improvement her mother had experienced in the 3 weeks of treatment:
..."Although he has not undergone any more tests, the change is evident, even without receiving chemotherapy. She gets up, cooks and has already started to eat everything"...
By September, after two months of treatment with LifEscozul, Maria has managed to recover her quality of life and maintain it.
He has managed to overcome the prognosis of the local doctors in one month and although he has not yet undergone new tests, he reports feeling well.
At that time, we proceed with a dose increase of LifEscozul (escozul, blue scorpion venom), the most advanced and effective formulation of blue scorpion venom.
By December 27, 2018, the local medical board informs Mary that the cancer was arrested.
Again, the dose of LifEscozul is increased.
As of March 2019, the disease remains arrested without change. Maria maintains her quality of life. She has gained weight. Exactly 10 pounds.
And in September 2019 we received a new scanner from Mary:
The report indicated that there was no tumor recurrence, nor was the disease present in any of the previous locations. Pamela informed us that she was discharged from Oncology, but continuing with palliative care due to the patient's condition because of her total gastrectomy. In March 2020 Maria continues the same, with optimal quality of life, independent and without the presence of the disease.
Gastric cancer is one of the most complex cancers to treat where most of the time, like Maria, we proceed with a total gastrectomy, which is the removal of the stomach. However, in Maria's case, the presence of the disease was detected at the level of the lung and when this happens the options are reduced.
Maria was sent home, the doctors indicated one month to live and instructed family members to make the best of her last moments. However, Maria's daughter Pamela decided to use that month to not give up. She asked us to enter her mother into the LifEscozul protocol.
The case was analyzed by our Medical Committee, who focused on seeking a superior quality of life and overcoming this prognosis. A responsible physician was assigned, a specific and changing dosage regimen was determined, staggered over time and periodically reviewed.
Maria started to improve after 3 weeks.
She began to gain weight despite the limitation of not having a stomach. Maria, after two years of treatment. Today, not only has she overcome the initial prognosis of one month of life, but the disease is no longer in her body.
Undoubtedly, it has been a huge result. It is the result of the work developed by the LifEscozul Protocol and Maria's decision not to give up.
We are the LifEscozul Group and Results Define Us.
Breast cancer is the most common cancer among women and is the second leading cause of death from cancer. View more